Globus Medical Inc. (GMED)
Globus Medical (GMED) Upgraded to Strong Buy: Here's What You Should Know
Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
GMED vs. SONVY: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value investors?
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED)
Globus Medical (GMED) could produce exceptional returns because of its solid growth attributes.
Down 13.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Globus Medical (GMED)
The heavy selling pressure might have exhausted for Globus Medical (GMED) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Globus Medical Q1 Earnings Call Highlights
Globus Medical NYSE: GMED reported a strong start to 2026, with first-quarter revenue and earnings rising sharply as the company cited continued momentum in U.S. spine, margin expansion and contributions from its Nevro acquisition.
GMED Stock Rises on Q1 Earnings & Revenue Beat, '26 EPS View Raised
Globus Medical beats Q1 EPS estimates by 22% as revenues rise 27% to $759.9M; margins widen and 2026 EPS outlook up, lifting shares 5.8%.
Globus Medical (GMED) Tops Q1 Earnings and Revenue Estimates
Globus Medical (GMED) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.68 per share a year ago.
Globus Medical, Inc. (GMED) Q1 2026 Earnings Call Transcript
Globus Medical, Inc. (GMED) Q1 2026 Earnings Call Transcript
Compared to Estimates, Globus Medical (GMED) Q1 Earnings: A Look at Key Metrics
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Globus Medical (GMED) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
Get a deeper insight into the potential performance of Globus Medical (GMED) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
GMED vs. IDXX: Which Stock Should Value Investors Buy Now?
Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value investors?
